C17ORF42 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.539200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.728600E-01
Normal-vs-Stage2
3.323200E-01
Normal-vs-Stage3
1.115610E-01
Normal-vs-Stage4
8.077800E-01
Stage1-vs-Stage2
1.951840E-01
Stage1-vs-Stage3
6.409900E-02
Stage1-vs-Stage4
8.173000E-01
Stage2-vs-Stage3
9.976300E-02
Stage2-vs-Stage4
4.343800E-01
Stage3-vs-Stage4
1.032960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.911800E-01
Normal-vs-AfricanAmerican
5.949800E-01
Normal-vs-Asian
1.008760E-01
Caucasian-vs-AfricanAmerican
7.202600E-01
Caucasian-vs-Asian
3.315600E-01
AfricanAmerican-vs-Asian
2.486600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.137200E-01
Normal-vs-Female
2.954600E-01
Male-vs-Female
7.351200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.870600E-01
Normal-vs-Age(41-60Yrs)
5.860000E-01
Normal-vs-Age(61-80Yrs)
2.711000E-01
Normal-vs-Age(81-100Yrs)
4.228400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.756600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.035000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.683400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.498150E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.155600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.774600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.465760E-01
Normal-vs-Daily Drinker
2.143400E-01
Normal-vs-Weekly Drinker
3.162800E-01
Normal-vs-Occasional Drinker
8.138000E-01
Normal-vs-Social Drinker
4.744600E-01
Non Drinker-vs-Daily Drinker
7.558400E-01
Non Drinker-vs-Weekly Drinker
5.442800E-01
Non Drinker-vs-Occasional Drinker
1.851620E-02
Non Drinker-vs-Social Drinker
6.944400E-02
Daily Drinker-vs-Weekly Drinker
7.537600E-01
Daily Drinker-vs-Occasional Drinker
5.485600E-02
Daily Drinker-vs-Social Drinker
1.524980E-01
Weekly Drinker-vs-Occasional Drinker
1.604400E-01
Weekly Drinker-vs-Social Drinker
3.233400E-01
Occasional Drinker-vs-Social Drinker
5.375400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.099800E-01
Normal-vs-Grade 2
7.650400E-01
Normal-vs-Grade 3
7.159400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.889000E-01
Grade 1-vs-Grade 3
6.241200E-01
Grade 1-vs-Grade 4
4.099800E-01
Grade 2-vs-Grade 3
2.894800E-01
Grade 2-vs-Grade 4
7.650400E-01
Grade 3-vs-Grade 4
7.159400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.433400E-01
Normal-vs-NonDiabetic
2.888000E-01
Diabetic-vs-NonDiabetic
2.141400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.848040E-01
Normal-vs-NoPancreatitis
2.903600E-01
Pancreatitis-vs-NoPancreatitis
5.313200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.867600E-01
Normal-vs-N1
2.964400E-01
N0-vs-N1
2.114400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.130000E-01
Normal-vs-TP53-NonMutant
7.857600E-01
TP53-Mutant-vs-TP53-NonMutant
8.270600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
